HOME >> BIOLOGY >> NEWS
Carnegie Mellon develops new process for growing bone

PITTSBURGH-- Carnegie Mellon University's Jeffrey Hollinger and his research team will receive $1.12 million over the next four years from the National Institutes of Health (NIH) to develop a new therapy for regenerating bone.

Bone, often called the structural steel and reinforced concrete of the human body, supports the body the way a steel framework supports a skyscraper, and it protects its vital organs the way a cast-concrete roof protects' its building occupants. "Unfortunately, bone loss is an unavoidable consequence of aging, osteoporosis and many traumatic accidents,'' Hollinger said.

To address the challenges of safe and effective therapy to restore form and function to deficient bone architecture, Hollinger's research team at Carnegie Mellon's Bone Tissue Engineering Center has developed an innovative therapy for growing bone by inserting a non-viral gene into the body to induce cells to grow bone.

"We are injecting the NTF gene into a site where bone is deficient via a synthetic hydro-gel made from a hyaluronic acid-based polymer,'' Hollinger said. "The hydro-gel/NTF is non-immunogenic and is designed to restore form and function to bone deficiencies.''

Some of the first pre-clinical trials will involve growing bone in the jaw, said Hollinger. And according to transportation officials, about 10 percent of vehicle accident injuries involve the jaw and the flat bones in the face. "Restoring periodontal bone loss is a high priority for our team, and Bruce Doll, head of the Department of Periodontology at the University of Pittsburgh is leading this challenge,'' Hollinger said.

Through ever-improving surgical techniques, the replacement of bone has been done via bone grafting either from the patient's own body or from animal (usually cow) bone. But because the human body is inclined to reject most 'non-self' grafts, Hollinger's synthetic approach to growing bone will eliminate immune rejections. His research team includes D
'"/>

Contact: Chriss Swaney
swaney@andrew.cmu.edu
412-268-5776
Carnegie Mellon University
13-Aug-2003


Page: 1 2

Related biology news :

1. Carnegie Mellon researcher tests tools for protecting Anacostia River ecosystem from PCBs
2. Carnegie Mellon scientists reveal ways of studying, resolving PCB contamination in US rivers
3. PCB breakdown in rivers depends on sediment-specific bacteria, find Carnegie Mellon U. scientists
4. Carnegie Mellon researchers to demonstrate autonomous robotthat will seek life in Atacama Desert
5. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
6. Carnegie Mellon neuroscientist develops tool to image brain function at the cellular level
7. Carnegie Mellon U. imaging study reveals sex-based differences that persist as mice enter adulthood
8. Carnegie Mellon computational biologist Russell Schwartz receives prestigious CAREER award
9. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly
10. Carnegie Mellon U. develops microgel to recover enzymes for manufacturing, research assays
11. Carnegie Mellon U. conducts first comprehensive proteomic analysis of developing animal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/5/2020)... ... March 05, 2020 , ... With numerous products in its ... to accelerate Cytonus’ existing products and to expand the companies’ intellectual property assets. ... biotech company located in Austria. , Phoenestra has developed IP assets in ...
(Date:3/5/2020)... (PRWEB) , ... March 05, 2020 , ... ... AlphaSTEM Test™ technology . The AlphaSTEM Test™ is the first, and ... stem cells. Other technologies that attempt to provide information about the number ...
(Date:3/4/2020)... , ... March 04, 2020 , ... ... working cell banks and hMSC bioprocess systems, announces today a significant milestone in ... innovative cellular starting materials. The patient has been treated by RoosterBio’s pharmaceutical customer ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... ... March 30, 2020 , ... A joint venture between mobile ... earlier this year to bring telehealth to various government agencies, has now focused ... officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from the FDA?to?perform?AI?testing in ...
(Date:3/27/2020)... ... March 26, 2020 , ... iFirst Medical Technologies, Inc., ... of COVID-19 nasal swab test. , "COVID-19 poses a grave danger to public health ... "We at iFirst are compelled to act. Broad-based testing and on-the-spot results promise to ...
(Date:3/10/2020)... ... ... Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving ... of extended antigen in a gel testing format used for blood phenotyping for patients ... Max in the United States and Canada. The clearances allow testing for more than ...
(Date:3/3/2020)... ARLINGTON HEIGHTS, Ill. (PRWEB) , ... March 03, ... ... software solutions company serving the pharmaceutical, biotech and medical device industries, was recognized ... , INC. 5,000 puts forward annual lists to note industry leaders greatly impacting ...
Breaking Biology Technology:
Cached News: